Belzutifan for Metastatic TFE3 ‐Rearranged Renal Cell Carcinoma With Pulmonary Metastases: A Case Report
IJU Case Reports · 2026-07 · 9 (4)
DOI: 10.1002/iju5.70202 ↗Kurz gefasst
Fallbericht in der Zeitschrift IJU Case Reports, online erschienen am 28.05.2026. Verfasst von Kazutaka Nakamura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Tokyo Women's Medical University Shinjuku-ku Tokyo Japan. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Belzutifan is effective in patients with previously treated advanced clear cell renal cell carcinoma. However, evidence for its use in non‐clear cell renal cell carcinoma remains limited. Case Presentation A 33‐year‐old Japanese woman underwent total nephrectomy for a 10‐cm renal tumor with lung metastases. The histological and immunohistochemical results were consistent with TFE3 ‐rearranged renal cell carcinoma. She was administered belzutifan as fourth‐line therapy. Her inflammatory markers normalized. After 4 weeks, computed tomography showed a decrease in the number and size of the pulmonary metastases, although the nodal lesions and local recurrence remained stable. At 12 weeks, chest radiography revealed improvement in both the bilateral nodular lesions and infiltrative opacities. No grade ≥ 3 adverse events occurred, as supportive care for anemia‐related complications was provided.
Conclusion
Belzutifan led to radiographic improvement in pulmonary metastases and symptoms, while other lesions remained stable. This suggests its potential therapeutic use in TFE3 ‐rearranged renal cell carcinoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology Tokyo Women's Medical University Shinjuku-ku Tokyo Japan.
- Department of Surgical Pathology Tokyo Women's Medical University Shinjuku-ku Tokyo Japan.
ORCID-Profile: Kazutaka Nakamura, Yoji Nagashima, Toshio Takagi
Zitieren
APA
Nakamura, K., Kumono, A., Kobari, Y., Seki, A., Nakayama, T., Fukuda, H., Yoshida, K., Iizuka, J., Nagashima, Y., & Takagi, T. (2026). Belzutifan for Metastatic TFE3 ‐Rearranged Renal Cell Carcinoma With Pulmonary Metastases: A Case Report. IJU Case Reports, 9(4). https://doi.org/10.1002/iju5.70202
Vancouver
Nakamura K, Kumono A, Kobari Y, Seki A, Nakayama T, Fukuda H, et al. Belzutifan for Metastatic TFE3 ‐Rearranged Renal Cell Carcinoma With Pulmonary Metastases: A Case Report. IJU Case Reports. 2026;9(4). doi:10.1002/iju5.70202
BibTeX
@article{Nakamura2026,
author = {Nakamura, Kazutaka and Kumono, Akihiro and Kobari, Yuki and Seki, Atsuko and Nakayama, Takayuki and Fukuda, Hironori and Yoshida, Kazuhiko and Iizuka, Junpei and Nagashima, Yoji and Takagi, Toshio},
title = {Belzutifan for Metastatic TFE3 ‐Rearranged Renal Cell Carcinoma With Pulmonary Metastases: A Case Report},
journal = {IJU Case Reports},
year = {2026},
volume = {9},
number = {4},
doi = {10.1002/iju5.70202}
}
EUVIMED